« All News & Opportunities

13th June 2022

Midatech Pharma Outlines Board Changes

R&D biotechnology company Midatech Pharma has revealed changes to its board, following its chairman announcing his intention to retire.

Rolf Stahel will step down from the board on 20 June 2022 and it is expected that Stephen Parker will be appointed as non-executive chairman, following the AGM.

Parker will join the Cardiff-based company, which works on improving the bio-delivery and biodistribution of medicines, with more than 30 years’ experience in leadership roles both in the healthcare industry and in advisory roles.

He is chairman of Sareum Holdings and Drishti Discoveries, a non-executive director of MGC Pharmaceuticals and an executive director of sp2 Consulting Limited.

Parker has an MBA from City University and a D.Phil. in biochemistry from Oxford University.

Stephen Stamp, chief executive and chief financial officer of Midatech, said: “On behalf of all stakeholders I would like to thank Rolf for his contribution to Midatech over the last seven years and, from a personal perspective, for his leadership and counsel during my tenure over the last two years.  We wish him well in his much-deserved retirement.

“I should also like to welcome Stephen to the board.  Stephen’s broad experience both as an executive in, and senior adviser to, the industry will be invaluable to Midatech in the next stage of the company’s evolution.  I am very much looking forward to working with Stephen.”

Parker added: “It is a great pleasure to be proposed as a director and chairman of Midatech whose technology base I have long admired.  It is a particular privilege to be asked to succeed Rolf Stahel and I join Stephen in thanking Rolf for his leadership to date. I look forward to working with the Midatech Board and team.”

Stahel said: “I am handing over the chairman function to Stephen Parker whose proposed appointment has the unanimous support from the directors of Midatech.  I have full confidence that Stephen Parker and Stephen Stamp, together with the other non-executive directors will form a powerful team leading Midatech to its promising future. I would like to thank all stakeholders for the support I have received over the last seven years.”